Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo

The P2X7 receptor is associated with the death of many cell types, and growing evidence supports its presence on neurons. Activation of the P2X7 receptor on isolated retinal ganglion cells increases intracellular calcium levels and can kill the cells. Within the intact eye, however, glia and other cell types surrounding the ganglion cells may provide protection and attenuate the effects of receptor stimulation. This investigation thus asks whether stimulation of the P2X7 receptor can actually kill retinal ganglion cells in vivo. Drugs were injected intravitreally into the superior/nasal region of Long Evans rats. Cell survival was determined by counting the number of remaining ganglion cells labeled with aminostilbamidine. The P2X7 receptor agonist BzATP reduced ganglion cell survival as compared to eyes injected with saline solution. Ganglion cell death was inhibited by co-injection of the P2X7 antagonists Brilliant Blue G and MRS 2540. The loss of ganglion cells following activation of the P2X7 receptor was also prevented by the adenosine A3 adenosine receptor agonist MRS 3558. In conclusion, stimulation of the P2X7 receptor can kill retinal ganglion cells in vivo. The neuroprotective effects of A3 receptor activation identified in isolated ganglion cells are also apparent in vivo. This implies that the balance between extracellular ATP and its protective metabolite adenosine can influence ganglion cell survival in the living eye.

Research Highlights:
► Stimulation of P2X7 receptor for ATP kills retinal ganglion cells in vivo,
► Block of P2X7 receptor with antagonists BBG or MRS 2540 protects neurons,
► Stimulation of A3 adenosine receptor neuroprotective,
► Suggests balance of purines alters ganglion cell fate in vivo like in vitro